Amin Sabet to Thyroxine
This is a "connection" page, showing publications Amin Sabet has written about Thyroxine.
Connection Strength
0.310
-
Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 May 02; 390(17):1632.
Score: 0.225
-
Sabet A, Kim M. Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am. 2010 Apr; 43(2):329-51, viii-ix.
Score: 0.085
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.